α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Biochemistry and Cell Biology

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biocel.2013.05.015PMID 23726834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2012

  2012cited by this paper
• Sialyl-Tn in Cancer: (How) Did We Miss the Target?

  2012cited by this paper
• Regulation of glycosyltransferases and Lewis antigens expression by IL-1β and IL-6 in human gastric cancer cells

  2011cited by this paper
• A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways.

  2011cited by this paper
• Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.

  2011cited by this paper
• The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach.

  2011cited by this paper
• Overexpression of GalNAc-transferase GalNAc-T3 Promotes Pancreatic Cancer Cell Growth

  2011cited by this paper
• Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival

  2011cited by this paper
• A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin‐mediated signaling

  2010cited by this paper
• Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells.

  2010cited by this paper
• α2,3-Sialyltransferase ST3Gal III Modulates Pancreatic Cancer Cell Motility and Adhesion In Vitro and Enhances Its Metastatic Potential In Vivo

  2010cited by this paper
• Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia.

  2009cited by this paper
• Expression of UDP-N-acetyl-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase-6 in Gastric Mucosa, Intestinal Metaplasia, and Gastric Carcinoma

  2009cited by this paper
• ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function

  2008cited by this paper
• Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.

  2008cited by this paper
• Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells.

  2007cited by this paper
• Changes in the invasive and metastatic capacities of HT‐29/M3 cells induced by the expression of fucosyltransferase 1

  2007cited by this paper
• Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells.

  2006cited by this paper
• NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha.

  2006cited by this paper
• Phenotypic changes induced by expression of β-galactoside α2,6 sialyltransferase I in the human colon cancer cell line SW948

  2006cited by this paper
• Fucosylation in prokaryotes and eukaryotes.

  2006cited by this paper
• Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.

  2006cited by this paper
• NFκB-p65 Dependent Transcriptional Regulation of Glycosyltransferases in Human Colon Adenocarcinoma HT-29 by Stimulation with Tumor Necrosis Factor α

  2006cited by this paper
• Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.

  2005cited by this paper
• Altered mRNA expressions of sialyltransferases in ovarian cancers.

  2005cited by this paper
• Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells

  2005cited by this paper
• Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.

  2005cited by this paper
• The discovery, biology, and drug development of sialyl Lea and sialyl Lex.

  2004cited by this paper
• 造血器腫瘍におけるmultiplex reverse transcription polymerase chain reaction法の有用性

  2004cited by this paper
• Correlation of glycosyltransferases mRNA expression in extrahepatic bile duct carcinoma with clinical pathological characteristics.

  2004cited by this paper
• Mucins in cancer: protection and control of the cell surface

  2004cited by this paper
• Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis

  2004cited by this paper
• Prognostic significance of UDP‐N‐acetyl‐α‐D‐galactosamine:polypeptide N‐acetylgalactosaminyltransferase‐3 (GalNAc‐T3) expression in patients with gastric carcinoma

  2003cited by this paper
• Clinical Relevance of Sialyltransferases ST6GAL-I and ST3GAL-III in Gastric Cancer

  2003cited by this paper
• Glycosyltransferase expression in human colonic tissue examined by oligonucleotide arrays.

  2003cited by this paper
• A "catastrophic hypothesis" for pancreas cancer progression.

  2003cited by this paper
• Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands

  2002cited by this paper
• Overexpression of Sialyl Lewis x Antigen Is Associated with Formation of Extratumoral Venous Invasion and Predicts Postoperative Development of Massive Hepatic Metastasis in Cases with Pancreatic Ductal Adenocarcinoma

  2002cited by this paper
• Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, α1,3 fucosyltransferase VII, and metastatic potential

  2002cited by this paper
• Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.

  2002cited by this paper
• Pancreatic cancer biology and genetics

  2002cited by this paper
• Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis.

  2002cited by this paper
• Expression of UDP‐N‐acetyl‐α‐D‐galactosamine–polypeptide galNAc N‐acetylgalactosaminyl transferase‐3 in relation to differentiation and prognosis in patients with colorectal carcinoma

  2002cited by this paper
• Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.

  2001cited by this paper
• Transfection of the c-erbB2/neu gene upregulates the expression of sialyl Lewis X, alpha1,3-fucosyltransferase VII, and metastatic potential in a human hepatocarcinoma cell line.

  2001cited by this paper
• Differential distribution of sialic acid in alpha2,3 and alpha2,6 linkages in the apical membrane of cultured epithelial cells and tissues.

  2001cited by this paper
• The human sialyltransferase family.

  2001cited by this paper
• Differential Distribution of Sialic Acid in α2,3 and α2,6 Linkages in the Apical Membrane of Cultured Epithelial Cells and Tissues

  2001cited by this paper
• Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells.

  2000cited by this paper
• Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas.

  1999cited by this paper
• Essentials of Glycobiology

  1999cited by this paper
• Molecular Cloning of a Novel α2,3-Sialyltransferase (ST3Gal VI) That Sialylates Type II Lactosamine Structures on Glycoproteins and Glycolipids*

  1999cited by this paper
• Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines.

  1998cited by this paper
• Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells

  1998cited by this paper
• Up-regulation of a set of glycosyltransferase genes in human colorectal cancer.

  1998cited by this paper
• Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer.

  1998cited by this paper
• Acceptor specificity of GDP-Fuc:Gal beta 1-->4GlcNAc-R alpha 3-fucosyltransferase VI (FucT VI) expressed in insect cells as soluble, secreted enzyme.

  1997cited by this paper
• Gene expression profiles in normal and cancer cells.

  1997cited by this paper
• Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.

  1997cited by this paper
• Acceptor specificity of GDP-Fuc:Galβ1→4GlcNAc-R α3-fucosyltransferase VI (FucT VI) expressed in insect cells as soluble, secreted enzyme

  1997cited by this paper
• Mouse β-galactoside α2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression

  1997cited by this paper
• Perspectives on the significance of altered glycosylation of glycoproteins in cancer

  1997cited by this paper
• Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells

  1996cited by this paper
• Acceptor specificity of different length constructs of human recombinant alpha 1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity.

  1995cited by this paper
• Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies.

  1995cited by this paper
• Hematogenous Metastases of Pancreatic Ductal Carcinoma

  1995cited by this paper
• Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups.

  1994cited by this paper
• Differential expression of five sialyltransferase genes in human tissues.

  1994cited by this paper
• Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection.

  1993cited by this paper
• Isolation of a novel human alpha (1,3)fucosyltransferase gene and molecular comparison to the human Lewis blood group alpha (1,3/1,4)fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities.

  1992cited by this paper
• Analysis of the lewisx epitope in human pancreas and pancreatic adenocarcinomas

  1992cited by this paper
• Molecular cloning of a fourth member of a human alpha (1,3)fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewis x, sialyl Lewis x, and difucosyl sialyl Lewis x epitopes.

  1992cited by this paper
• Expression of blood group‐related carbohydrate antigens in normal human pancreatic tissue

  1991cited by this paper
• Lex and Ley antigen expression in human pancreatic cancer.

  1988cited by this paper

• Antigen-Specific Ganglioside Serological Profile of Pancreatic and Gastric Cancer Patients by Multiple TLC Overlay Assay and IR-MALDI Mass Spectrometry.

  2026cites this paper
• ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (St3gal4) deficiency reveals correlations among alkaline phosphatase activity, metabolic parameters, and fear-related behavior in mice

  2025cites this paper
• A nanobody-enzyme fusion protein targeting PD-L1 and sialic acid exerts anti-tumor effects by C-type lectin pathway-mediated tumor associated macrophages repolarizing.

  2025cites this paper
• Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics

  2025cites this paper
• Building simplified cancer subtyping and prediction models with glycan gene signatures

  2025cites this paper
• Sialylated glycoproteins and sialyltransferases in digestive cancers: mechanisms, diagnostic biomarkers, and therapeutic targets.

  2024cites this paper
• The role of ST3GAL4 in glioma malignancy, macrophage infiltration, and prognostic outcomes

  2024cites this paper
• Specific sialylation of N-glycans and its novel regulatory mechanism

  2024cites this paper
• Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions

  2024cites this paper
• Role of tumor cell sialylation in pancreatic cancer progression.

  2023cites this paper
• Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review.

  2023cites this paper
• The Role of Paxillin Aberrant Expression in Cancer and Its Potential as a Target for Cancer Therapy

  2023cites this paper
• ST3GalIV drives SLeX biosynthesis in gastrointestinal cancer cells and associates with cancer cell motility

  2023cites this paper
• Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment

  2022cites this paper
• Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice

  2022cites this paper
• Role of a Disease-associated ST3Gal-4 in Non-small Cell Lung Cancer

  2022cites this paper
• Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera

  2022cites this paper
• Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?

  2022cites this paper
• Altered glycosylation in pancreatic cancer and beyond

  2022cites this paper
• The Effect of Asparagus Extract on Pancreatic Cancer: An Intriguing Surprise

  2022cites this paper
• Small molecule inhibitors of mammalian glycosylation

  2022cites this paper
• ST3Gal IV Mediates the Growth and Proliferation of Cervical Cancer Cells In Vitro and In Vivo Via the Notch/p21/CDKs Pathway

  2021cites this paper
• The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology

  2021cites this paper
• The Cancer-Associated Antigens Sialyl Lewisa/x and Sda: Two Opposite Faces of Terminal Glycosylation

  2021cites this paper
• Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives

  2021cites this paper
• α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.

  2021cites this paper
• Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.

  2021cites this paper
• Mucin-Type O-GalNAc Glycosylation in Health and Disease.

  2021cites this paper
• Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?

  2021cites this paper
• Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9

  2021cites this paper
• Recent advances in understanding the roles of sialyltransferases in tumor angiogenesis and metastasis

  2021cites this paper
• ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer

  2020cites this paper
• Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis

  2020cites this paper
• Sialic acids and sialoglycans in endocrinal disorders

  2020cites this paper
• Correction: Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis

  2020cites this paper
• Identification and characterization of the V3 promoter of the ST3GAL4 gene.

  2020cites this paper
• Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application

  2020cites this paper
• Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen–Defined Pancreatic Cancer Tissues

  2020cites this paper
• Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis.

  2020cites this paper
• Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models.

  2020cites this paper
• Imaging Mass Spectrometry and Lectin Analysis of N-linked Glycans in Carbohydrate Antigen Defined Pancreatic Cancer Tissues.

  2020cites this paper
• L1CAM as an E-selectin Ligand in Colon Cancer

  2020cites this paper
• Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.

  2020cites this paper
• Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl Lewis X (sLex) in pancreatic adenocarcinoma.

  2020cites this paper
• Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion

  2020cites this paper
• ST3GAL3, ST3GAL4, and ST3GAL6 differ in their regulation of biological functions via the specificities for the α2,3‐sialylation of target proteins

  2020cites this paper
• Protein glycosylation in head and neck cancers: From diagnosis to treatment.

  2020cites this paper
• Significance of Altered Glycosylation in Oral Cancer

  2019cites this paper
• The glycosylation landscape of pancreatic cancer

  2019cites this paper
• THE RELEVANCE OF LONG NON-CODING RNA IN THE BIOLOGICAL AND CLINICAL HETEROGENEITY OF MULTIPLE MYELOMA

  2019cites this paper
• I-branched carbohydrates as emerging effectors of malignant progression

  2019cites this paper
• Computational analysis of the structure, glycosylation and CMP binding of human ST3GAL sialyltransferases.

  2019cites this paper
• Aberrant sialylation plays a significant role in oral squamous cell carcinoma progression.

  2019cites this paper
• Expression analysis of ST3GAL4 transcripts in cervical cancer cells.

  2018cites this paper
• Computer‐aided design of human sialyltransferase inhibitors of hST8Sia III

  2018cites this paper
• Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities

  2018cites this paper
• Glycosylation and metastases

  2018cites this paper
• Knockdown of FUT3 disrupts the proliferation, migration, tumorigenesis and TGF-β induced EMT in pancreatic cancer cells

  2018cites this paper
• Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma

  2018cites this paper
• Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.

  2018cites this paper
• Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/mTOR-mediated pathway in pancreatic cancer cells

  2018cites this paper
• Expression analysis of ST 3 GAL 4 transcripts in cervical cancer cells

  2018cites this paper
• Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression.

  2017cites this paper
• Enhanced expression of α2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.

  2017cites this paper
• Consecució i validació del silenciament de ST3GAL4 en línies cel·lulars de càncer de pàncrees: optimització de la metodologia

  2017influential citation
• Characterization of gastric cancer glycosylation profile for the discovery of biomarkers

  2017cites this paper
• New Avenues in the Design of Sialyltransferase Inhibitors

  2017cites this paper
• Multiple myeloma: The role of glycosylation in disease development and progression.

  2017cites this paper
• Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities

  2017cites this paper
• MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1.

  2017cites this paper
• Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation

  2017cites this paper
• E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271

  2017cites this paper
• Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers

  2017cites this paper
• Role of protein glycosylation in cancer metastasis.

  2017cites this paper
• Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer.

  2016cites this paper
• Pancreatic cancer markers based on aberrant glycosylation of serum proteins

  2016cites this paper
• Fucosylation is associated with the malignant transformation of intraductal papillary mucinous neoplasms: a lectin microarray-based study

  2016cites this paper
• Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer

  2016cites this paper
• Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer.

  2016cites this paper
• Sialic acids: biomarkers in endocrinal cancers

  2015cites this paper
• Solution-Phase Nuclear Magnetic Resonance Studies of a Nonribosomal Peptide Synthetase Adenylation Domain, of a Bacterial Glycosyltransferase, and the Rational Design of Inhibitors and Mutants of Glycosyltransferases

  2015cites this paper
• Glycosylation characteristics of colorectal cancer.

  2015cites this paper
• Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer

  2015cites this paper
• Mass Spectrometry-Based N-Glycomics of Colorectal Cancer

  2015cites this paper
• Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue

  2015cites this paper
• The cancer glycome: carbohydrates as mediators of metastasis.

  2015cites this paper
• Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.

  2015cites this paper
• Regulation and function of silayltransferases in pancreatic cancer

  2014cites this paper
• Prognostic relevance of glycosylation-associated genes in breast cancer

  2014cites this paper
• Inflammatory cytokines regulate the expression of g lycosyltransferases involved in the biosynthesis of tumor-associated sialylated gly cans in pancreatic cancer

  2014cites this paper
• Pancreatic Cancer Cell Glycosylation Regulates Cell Adhesion and Invasion through the Modulation of α2β1 Integrin and E-Cadherin Function

  2014cites this paper
• Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression.

  2014cites this paper
• TRANSCRIPTIONAL REGULATION OF THE B3GALT5 GENE

  2014cites this paper
• Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1

  2014cites this paper